The biotech’s efforts to bring its vaccines to the country mean navigating political pushback in the U.S. and the risk of ...
In absolute dollar amount, the Cambridge drugmaker had the biggest drop in market cap among any public Massachusetts company ...
With COVID vaccine sales in the doldrums and a respiratory syncytial virus (RSV) vaccine market in “contraction”, Moderna CEO ...
Fierce Pharma Asia—A $410M obesity debut; Another Roche ADC deal; Legend, BeiGene as buyout targets?
A new weight loss biotech launched with $410 million and three assets from China. Roche's Chugai penned a deal to develop ...
Bloomberg on MSN2mon
Moderna’s Bancel Steps Down as Sales Chief, Keeps CEO Role(Bloomberg) -- Stephane Bancel is stepping down as chief commercial officer of Moderna Inc., according to a person familiar ...
The company is one of a few drugmakers currently developing a vaccine for the illness, which is spreading rapidly through ...
Hosted on MSN1mon
Moderna CEO says he'll work with Trump using 'facts and data'Moderna (MRNA) CEO Stéphane Bancel said that he plans to address any partisan hurdles with the incoming Trump administration’s vaccine and pandemic preparedness policies with “facts and data.” ...
Breaktime had help from many donors, including three prominent philanthropic couples: Stephane Bancel and Brenda Bancel (through Bancel Philanthropies), Jeannie Lavine and Jonathan Lavine (through ...
In the mRNA vaccine maker’s 2024 Shareholder Letter, CEO Stéphane Bancel reflected upon the company’s second year ...
The challenge of maintaining the earlier growth achieved by US mRNA medicines specialist Moderna through its COVID vaccine ...
Here are the five things you need to know, including the national day of mourning for Jimmy Carter, California wildfires, Newbury Street rents, and quality goat time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback